These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24466333)

  • 1. Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A.
    Kales SC; Nau MM; Merchant AS; Lipkowitz S
    PLoS One; 2014; 9(1):e87116. PubMed ID: 24466333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
    Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
    J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.
    Ryan PE; Kales SC; Yadavalli R; Nau MM; Zhang H; Lipkowitz S
    PLoS One; 2012; 7(11):e49428. PubMed ID: 23145173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
    Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
    J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting.
    Carniti C; Perego C; Mondellini P; Pierotti MA; Bongarzone I
    Cancer Res; 2003 May; 63(9):2234-43. PubMed ID: 12727845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of function Cbl-c mutations in solid tumors.
    Daniels SR; Liyasova M; Kales SC; Nau MM; Ryan PE; Green JE; Lipkowitz S
    PLoS One; 2019; 14(7):e0219143. PubMed ID: 31260484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
    Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
    J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins.
    Davies GC; Ryan PE; Rahman L; Zajac-Kaye M; Lipkowitz S
    Oncogene; 2006 Oct; 25(49):6497-509. PubMed ID: 16702950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
    Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
    Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
    J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation of ret signal transduction.
    Tsui CC; Pierchala BA
    J Neurosci; 2008 Aug; 28(35):8789-800. PubMed ID: 18753381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.
    Scott RP; Eketjäll S; Aineskog H; Ibáñez CF
    J Biol Chem; 2005 Apr; 280(14):13442-9. PubMed ID: 15677445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cbl interacts with multiple E2s in vitro and in cells.
    Liyasova MS; Ma K; Voeller D; Ryan PE; Chen J; Klevit RE; Lipkowitz S
    PLoS One; 2019; 14(5):e0216967. PubMed ID: 31120930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
    Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
    Front Immunol; 2020; 11():1559. PubMed ID: 32849529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain.
    Durick K; Wu RY; Gill GN; Taylor SS
    J Biol Chem; 1996 May; 271(22):12691-4. PubMed ID: 8662982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
    Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
    Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin ligase Cbl-b acts as a negative regulator in discoidin domain receptor 2 signaling via modulation of its stability.
    Yu J; Zhao H; Zhang Y; Liu YC; Yao L; Li X; Su J
    FEBS Lett; 2014 May; 588(9):1509-14. PubMed ID: 24631539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbl-b and c-Cbl negatively regulate osteoblast differentiation by enhancing ubiquitination and degradation of Osterix.
    Choi YH; Han Y; Lee SH; Jin YH; Bahn M; Hur KC; Yeo CY; Lee KY
    Bone; 2015 Jun; 75():201-9. PubMed ID: 25744063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
    Visser GD; Lill NL
    Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
    Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
    Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.